Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

Periodontal Therapeutics Market Research Report Information By Type (Chronic Periodontitis, Aggressive Periodontitis and Necrotizing Periodontal), By Treatment (Systematic Antibiotics and Others), By End Users (Dental Hospital and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032.

ID: MRFR/Pharma/5100-HCR | 100 Pages | Author: Rahul Gotadki| April 2024

Global Periodontal Therapeutic Market Overview

Periodontal Therapeutics Market Size was valued at USD 0.3 billion in 2022 and is projected to grow from USD 0.3 Billion in 2023 to USD 0.73 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.3% during the forecast period (2023 - 2032). Due to the rise in oral health problems worldwide, periodontal therapy is expanding quickly. The development of novel therapeutic products with the assistance of numerous organizations accelerates the market growth. These are major market drivers for the expansion of market.Periodontal Therapeutic Market Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Periodontal Therapeutic Market Trends

  • Rise in the number of individuals with Periodontitis to boost the market growth

A chronic inflammatory condition known as the periodontal disease affects the bone-supporting teeth and the gums. Left untreated may lead to tooth loss and other serious health problems. Early treatment of periodontal disease is necessary to prevent chronic inflammation, which raises the risk of diabetes, insulin resistance, and decreased glucose tolerance. The earlier it is addressed, the better. Almost 90% of people worldwide are afflicted with periodontal diseases, making them the most prevalent dental condition. Globally, the prevalence of oral disorders is rising due to expanding urbanization and modifications in livable conditions. Periodontitis affects an estimated 3.5 billion individuals worldwide, according to the World Health Organization (WHO). Furthermore, more than 1 billion adults worldwide, or around 19% of the adult population, are thought to be affected by severe periodontal diseases.

The Centers for Disease Control and Prevention estimate that 42.2% of persons 30 and older have periodontal disease. The condition in the United States afflicts more males than women. As a result, the prevalence of periodontal illnesses raises the need for treatment, which fuels the growth of the periodontal treatment industry.

Periodontal Therapeutic Market Segment Insights

Periodontal Therapeutic Type Insights

The Periodontal Therapeutics Market segmentation, based on type, includes chronic Periodontitis, aggressive Periodontitis, and necrotizing periodontal. The chronic periodontitis segment held the majority share in 2022, contributing to around ~65-67% of the Periodontal Therapeutics Market revenue. This is primarily owing to the rising prevalence of periodontitis disease and the growing aging population across the globe. The prevalence of tooth gum disease is typically proportional to age, as the age of the population increases, the prevalence of Periodontitis or oral healthcare issues increases.

Whereas the aggressive periodontitis segment is expected to grow at the fastest growth rate. The aggressive periodontitis market is expanding significantly due to aggressive Periodontitis being more prevalent in a diverse population of younger people who may or may not be otherwise healthy.

The FDA approved the cavity-spotting AI from VideaHealth. The AI was developed and trained using the vast collection of dental X-rays from VideaHealth's Videa Factory, which the company touts as the most diverse data set in the dental industry. Insurers, clearinghouses, institutions, and dental service providers have contributed over 100 million data points. According to reports, AI has enabled dentists to miss 43% fewer caries lesions. They made 15% fewer incorrect diagnoses as a result.

Periodontal Therapeutic Treatment Insights

The Periodontal Therapeutics Market segmentation based on treatment includes systematic antibiotics and others. The systematic antibiotics segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. Surgical procedures are recommended less often than systemic antibiotic therapies, such as periodontal scaling, root planing, and antibiotics for periodontal disease treatment. Systematic antibiotics are in high demand since they are less invasive than surgery, less painful, and take less time to complete.

The treatment of adult patients with locally advanced or metastatic differentiated thyroid carcinoma (DTC) who are refractory to radioactive iodine (RAI) or who are ineligible for RAI and who have progressed during or after prior systemic therapy has recently received approval from the European Commission for CABOMETYX (cabozantinib) as a monotherapy. With this permission, CABOMETYX may be marketed for this use in all 27 members of the European Union, as well as in Norway, Liechtenstein, and Iceland.

Periodontal Therapeutic End User Insights

End users have bifurcated the Periodontal Therapeutics Market data into dental hospitals and others. The dental hospital segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. For the majority of dental-related problems, people prefer to consult a dentist. As a result, dental clinic procedures have grown.

Due to the quick adoption of cutting-edge periodontal therapy goods and the accessibility of qualified dental, and medical professionals, dental hospitals held the greatest segment share. The expansion of the periodontal therapeutic market is also anticipated to be supported by rising government initiatives to enhance the oral healthcare infrastructure and the rising number of periodontal therapeutic procedures, including chronic periodontal surgery.

Figure 1: Periodontal Therapeutics Market by End User, 2022 & 2030 (USD billion)Periodontal Therapeutics Market by End User, 2022 & 2030Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Periodontal Therapeutic Regional Insights

By Region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. North America periodontal therapeutics market accounted for USD 0.14 billion in 2022 and is expected to exhibit a significant market share of 45.8% in 2022. This is attributed to a rise in scientific study and cutting-edge technology that may broaden the potential for periodontal therapy advancement. Over 47.2% of Americans aged 30 and over have periodontal disease, according to the Centers for Disease Control and Prevention. Age-related increases in prevalence are seen; 70.1% of persons 65 and older have periodontal disease. The need for periodontal therapy in the area has increased as a result.

Further, the major countries studied in the market report are The U.S., Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: PERIODONTAL THERAPEUTICS MARKET SHARE BY REGION 2022 (%)PERIODONTAL THERAPEUTICS MARKET SHARE BY REGION 2022Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Due to the availability of state-of-the-art treatment facilities, government support for expanding the dental healthcare sector, an aging population, and an increase in chronic and aggressive periodontitis illness, Europe periodontal therapeutics market holds the second-largest share. Also, the UK periodontal therapeutic market grew the fastest in the European Region, while Germany periodontal therapeutic market had the significant market share.

A higher CAGR is anticipated for the Asia Pacific periodontal therapeutics market throughout the projected period. The increase in oral disease prevalence is blamed for this. The burden of periodontal disease is greatest in Southeast Asia and the Western Pacific, whereas the prevalence is lowest, according to the Journal of Public Health & Emergency. The highest rise over the previous three years was likewise seen in the Western Pacific. The Region is also a very lucrative market due to the Region's increased knowledge, increased adoption of periodontal therapy, and increased assistance from governing authorities. Moreover, China periodontal therapeutics market held the largest market share, and the India periodontal therapeutics market was the fastest growing market in the Asia-Pacific region.

Periodontal Therapeutic Key Market Players & Competitive Insights

Major market players are investing heavily in R&D to expand their product lines, which will help the periodontal therapeutics market grow even further. Market participants are also pursuing a variety of strategic initiatives to expand their global footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. To expand and survive in an increasingly competitive and rising market environment, periodontal therapeutics industry must offer cost-effective items.

One of the primary business strategies adopted by manufacturers in the periodontal therapeutics industry to benefit clients and expand the market sector is to expand their production capacity and are adopt innovative technologies in order to meet consumer demand for periodontal therapeutics. The periodontal therapeutics market major player such as Fibrocell Sciences, Tolmar Inc, Eli Lilly & Company, and Align Technology. And others are working on expanding the market demand by investing in research and development activities.

Envista is an international group of more than 30 reputable dental companies with a common goal: to work with experts to enhance lives. Envista uses market-leading goods, solutions, and technology to assist its partners in providing the best patient care possible. An estimated 90% of dentists' clinical needs for diagnosing, treating, and preventing dental diseases are met by its complete portfolio, which includes dental implants and treatment alternatives, orthodontics, and digital imaging technology. Envista Holding Corporation and the Spanish dental services provider Vitaldent Group entered a strategic alliance in February 2022. This aids the business in being the go-to source for dental implants.

Also, The main provider of dental lasers and a pioneer in dental technology is AMD LASERS. For dentists ready to advance their practice, AMD has offered ultra-affordable laser technology for over ten years. To raise the bar for patient care, our mission is to guarantee that every dental practitioner and practice has access to cutting-edge medical and dental technologies and educational resources. The Monet laser cutting light, the first portable laser in curing light for dental materials, was introduced by AMD Lasers in February 2020.

Key Companies in the periodontal therapeutics market include

  • Fibrocell Sciences

  • Tolmar Inc

  • Eli Lilly & Company

  • Align Technology

  • Dentsply International

  • 3M-ESPE

  • Ultradent Products Inc

  • Nobel Biocare Holdings AG

  • Glidewell Laboratories

  • Orapharma

  • Kaken Pharmaceutical

  • Valeant Pharmaceuticals Int., among others

Periodontal Therapeutic Industry Developments

February 2022: The Vitaldent Group, a dental services provider with offices in Spain, and Envista Holdings Corporation have renewed their collaboration agreement to deliver implants and clear aligners.

March 2021: Positive topline phase 2 results from the randomized placebo-controlled clinical trial evaluating AMY101 in 39 patients with Periodontitis and gingivitis were released by Amyndas Pharmaceuticals.

Periodontal Therapeutic Market Segmentation

Periodontal Therapeutic Type Outlook

  • Chronic Periodontitis

  • Aggressive Periodontitis

  • Necrotizing Periodontal

Periodontal Therapeutic Treatment Outlook

Periodontal Therapeutic End User Outlook

  • Dental Hospital

  • Others

Periodontal Therapeutic Regional Outlook

  • North America

    • US

    • Canada

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific

  • Rest of the World

    • Middle East

    • Africa

    • Latin America

Report Attribute/Metric Details
Market Size 2022 USD 0.3 billion
Market Size 2023 USD 0.33 billion
Market Size 2032 USD 0.73 billion
Compound Annual Growth Rate (CAGR) 10.3% (2023-2032)
Base Year 2022
Market Forecast Period 2023-2032
Historical Data 2019 - 2021
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Type, Treatment, End User and Region
Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled Fibrocell Sciences, Tolmar Inc, Eli Lilly & Company, Align Technology,  Dentsply International,  3M-ESPE,   Ultradent Products Inc,  Nobel Biocare Holdings AG,  Glidewell Laboratories,  Orapharma,  Kaken Pharmaceutical, and Valeant Pharmaceuticals Int.
Key Market Opportunities High Demand for Non-surgical Periodontal Treatment
Key Market Dynamics Increase in the Number of Periodontitis Patients Sedentary Lifestyle, Unhealthy Diet, and Smoking

Frequently Asked Questions (FAQ) :

The Periodontal Therapeutics Market size was valued at USD 0.3 Billion in 2022.

The global market is projected to grow at a CAGR of 10.3% during the forecast period 2023-2032.

North America had the largest share of the global market.

The key players in the market are Fibrocell Sciences, Tolmar Inc, Eli Lilly & Company, and Align Technology.

The chronic periodontitis category dominated the market in 2022.

The systematic antibiotics segment had the largest share of the global market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample
Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Ask for Customization